145 related articles for article (PubMed ID: 11115693)
1. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.
Rueda P; Fominaya J; Langeveld JP; Bruschke C; Vela C; Casal JI
Vaccine; 2000 Nov; 19(7-8):726-34. PubMed ID: 11115693
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies against porcine parvovirus nonstructural protein NS1 may distinguish between vaccinated and infected pigs.
Madsen ES; Madsen KG; Nielsen J; Jensen MH; Lei JC; Have P
Vet Microbiol; 1997 Jan; 54(1):1-16. PubMed ID: 9050166
[TBL] [Abstract][Full Text] [Related]
3. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
[TBL] [Abstract][Full Text] [Related]
4. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.
Antonis AF; Bruschke CJ; Rueda P; Maranga L; Casal JI; Vela C; Hilgers LA; Belt PB; Weerdmeester K; Carrondo MJ; Langeveld JP
Vaccine; 2006 Jun; 24(26):5481-90. PubMed ID: 16730104
[TBL] [Abstract][Full Text] [Related]
5. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
6. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine.
Maranga L; Rueda P; Antonis AF; Vela C; Langeveld JP; Casal JI; Carrondo MJ
Appl Microbiol Biotechnol; 2002 Jun; 59(1):45-50. PubMed ID: 12073130
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
8. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.
Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J
Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
10. Use of parvovirus-like particles for vaccination and induction of multiple immune responses.
Casal JI
Biotechnol Appl Biochem; 1999 Apr; 29(2):141-50. PubMed ID: 10075910
[TBL] [Abstract][Full Text] [Related]
11. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera.
Wang Q; Ju H; Li Y; Jing Z; Guo L; Zhao Y; Ma B; Gao M; Zhang W; Wang J
J Virol Methods; 2014 Dec; 209():69-75. PubMed ID: 25196452
[TBL] [Abstract][Full Text] [Related]
13. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
14. Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs.
Ji P; Liu Y; Chen Y; Wang A; Jiang D; Zhao B; Wang J; Chai S; Zhou E; Zhang G
Antiviral Res; 2017 Mar; 139():146-152. PubMed ID: 28063996
[TBL] [Abstract][Full Text] [Related]
15. Immune complex-based vaccine for pig protection against parvovirus.
Roić B; Cajavec S; Ergotić N; Lipej Z; Madić J; Lojkić M; Pokrić B
J Vet Med B Infect Dis Vet Public Health; 2006 Feb; 53(1):17-23. PubMed ID: 16460351
[TBL] [Abstract][Full Text] [Related]
16. Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine.
Guo M; Qian Y; Chang KO; Saif LJ
J Clin Microbiol; 2001 Apr; 39(4):1487-93. PubMed ID: 11283075
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of the rVP-ELISA for detection of antibodies against porcine parvovirus.
Kong M; Peng Y; Cui Y; Chang T; Wang X; Liu Z; Liu Y; Zhu Y; Luo Y; Tang Q; Feng L; Cui S
J Virol Methods; 2014 Sep; 206():115-8. PubMed ID: 24945904
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
20. Expression and self-assembly of virus-like particles from porcine parvovirus and its application in antibody detection.
Li Y; Wang Q; Yue W; Li X; Chen Y; Gao Y
Pol J Vet Sci; 2023 Dec; 26(4):591-609. PubMed ID: 38088304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
